Project Grant HT9425261E275
Award Date 7/1/26
Completion Date 6/30/28
Dollars Obligated $559K
Federal Agency
Federal Grant Program
Assistance Type
Project Grant
Place of Performance
Stony Brook, NY 11794, USA
Similar Awards
- Federal Grant Award Summary New York University School of Medicine received a $750,962 Project Grant from the Defense Health Agency (DHA) under the Military Medical Research and Development program (CFDA 12.420), effective June 15, 2026 through June 14, 2029. The award supports research investigating "Neoadjuvant Checkpoint and IL-6 Blockade: Mechanisms of Benefit and Toxicity," focusing on understanding the therapeutic mechanisms and adverse effects associated with combination...
- The federal Project Grant award of $1,008,313 was provided by the Defense Health Agency under the Military Medical Research and Development (CFDA 12.420) program. This award supports advanced biomedical research aimed at transforming healthcare for military service members, veterans, and the broader public. The award was granted to The Regents of the University of California, San Francisco (UCSF), a prominent academic medical center and research institution, to conduct research on melanoma....
- Federal Grant Award Summary The Defense Health Agency (DHA) awarded Icahn School of Medicine at Mount Sinai a $1.23M Project Grant under the Military Medical Research and Development program (CFDA 12.420) effective July 1, 2025 through June 30, 2028. The award supports biomarker development research focused on refining an individualized risk-adapted approach to bladder-sparing treatment for muscle-invasive bladder cancer. This research initiative aims to advance clinical decision-making and...
- Federal Grant Award Summary The University of Michigan's Regents, through its Office of Research and Sponsored Projects, received a $559,046 Project Grant from the Defense Health Agency (DHA) under the Military Medical Research and Development program (CFDA 12.420) effective June 1, 2026, through May 31, 2028. The award supports research investigating biased protein phosphatase 2A heterotrimerization in the development and treatment of uveal melanoma. This fundamental and translational...
- Federal Grant Award Summary The University of California, San Francisco (UCSF) received a $1,054,812 Project Grant award from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420), effective August 15, 2026, through August 14, 2030. The grant funds research focused on "Biochemical and Structural Targeting of the GAQ-Mutant Melanoma Subtype," with performance conducted at UCSF's San Francisco, California facility. Under this award, UCSF will...
- Federal Project Grant Award Summary The Defense Health Agency (DHA) awarded Sloan-Kettering Institute for Cancer Research a Project Grant totaling $559,998 under the Military Medical Research and Development program (CFDA 12.420) for the period of June 1, 2026, through May 31, 2028. The award supports research focused on therapeutic targeting of RNA processing to enhance anti-melanoma immunotherapy. This research initiative aligns with the program's emphasis on hypothesis-driven biomedical...
- Federal Grant Award Summary New York University School of Medicine received a $1,346,697 Project Grant from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420), awarded June 15, 2026, with an ultimate completion date of June 14, 2029. The grant funds research investigating "Neoadjuvant Checkpoint and IL-6 Blockade: Mechanisms of Benefit and Toxicity," conducted at NYU's New York, New York location. This research initiative focuses on...
- Federal Project Grant Summary The Defense Health Agency (DHA) awarded The Wistar Institute of Anatomy and Biology a $1.10M Project Grant under the Military Medical Research and Development program (CFDA 12.420) for research titled "Immunotherapeutic Targeting of SLC39A9 in CDKN2A-Low Melanoma." The three-year award, effective September 15, 2025 through September 14, 2028, supports hypothesis-driven biomedical research designed to advance cancer immunotherapy approaches for melanoma....
- Federal Project Grant Award Summary The Defense Health Agency (DHA) awarded $352,000 under the Military Medical Research and Development program (CFDA 12.420) to the Sloan-Kettering Institute for Cancer Research for the project period September 1, 2025, through August 31, 2027. The award supports research focused on augmenting the in vivo efficacy of a novel lanosterol synthase inhibitor in glioblastoma treatment. This research aligns with the DHA's mission to transform healthcare for service...
- Federal Grant Award Summary The University of Virginia received a $638,260 Project Grant from the Defense Health Agency (DHA) under the Military Medical Research and Development program (CFDA 12.420), awarded September 1, 2025, with completion scheduled for August 31, 2027. The award supports research titled "Linking Genetic, Metabolic, and Microenvironmental Predictors of Melanoma Metastatic Colonization," conducted at the university's Charlottesville, Virginia campus. This research...